Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a highly vascularised and poor-prognosis tumour. NGR-hTNF is a vascular-targeting agent consisting of human tumour necrosis factor-alpha fused to the tumour-homing peptide NGR, which is able to selectively bind an aminopeptidase N overexpressed on tumour...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Santoro, A, Pressiani, T, Citterio, G, Rossoni, G, Donadoni, G, Pozzi, F, Rimassa, L, Personeni, N, Bozzarelli, S, Colombi, S, De Braud, F G, Caligaris-Cappio, F, Lambiase, A, Bordignon, C
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2010
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2966632/
https://ncbi.nlm.nih.gov/pubmed/20717115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605858
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados